170 related articles for article (PubMed ID: 12643165)
21. Long-acting insulin analogues and diabetic retinopathy: a retrospective cohort study.
Lin JC; Shau WY; Lai MS
Clin Ther; 2014 Sep; 36(9):1255-68. PubMed ID: 25082730
[TBL] [Abstract][Full Text] [Related]
22. Insulin aspart: a review of its use in the management of type 1 and 2 diabetes mellitus.
Chapman TM; Noble S; Goa KL
Drugs; 2002; 62(13):1945-81. PubMed ID: 12215068
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic efficacy of mitiglinide combined with once daily insulin glargine after switching from multiple daily insulin regimen of aspart insulin and glargine in patients with type 2 diabetes mellitus.
Yoshihara T; Kumashiro N; Kanazawa Y; Mita T; Sakurai Y; Kawai J; Abe M; Motojima K; Hara K; Yamazaki Y; Kanazawa A; Miwa S; Sato F; Kanno R; Shimizu T; Sakai K; Uchino H; Watada H; Tanaka Y; Kawamori R; Hirose T
Endocr J; 2006 Feb; 53(1):67-72. PubMed ID: 16543674
[TBL] [Abstract][Full Text] [Related]
24. Insulin glargine and its place in the treatment of Types 1 and 2 diabetes mellitus.
Chatterjee S; Tringham JR; Davies MJ
Expert Opin Pharmacother; 2006 Jul; 7(10):1357-71. PubMed ID: 16805721
[TBL] [Abstract][Full Text] [Related]
25. Long-acting insulin analogs versus human insulins.
Garg SK; Naik RG
Diabetes Technol Ther; 2008 Oct; 10(5):331-2. PubMed ID: 18715208
[No Abstract] [Full Text] [Related]
26. Basal insulin glargine vs prandial insulin lispro in type 2 diabetes.
Oliveira JH; Kazda C; Simpson A; Jackson JA; Heine RJ
Lancet; 2008 Aug; 372(9636):371-2; author reply 372. PubMed ID: 18675683
[No Abstract] [Full Text] [Related]
27. Insulin detemir: a review of its use in the management of type 1 and 2 diabetes mellitus.
Chapman TM; Perry CM
Drugs; 2004; 64(22):2577-95. PubMed ID: 15516157
[TBL] [Abstract][Full Text] [Related]
28. Comparison of one-year costs of type 2 diabetes treatment with insulin glargine or insulin detemir in a basal supported oral therapy (BOT) in Germany.
Pscherer S; Dietrich ES; Dippel FW; Neilson AR
Int J Clin Pharmacol Ther; 2010 Feb; 48(2):129-37. PubMed ID: 20137765
[TBL] [Abstract][Full Text] [Related]
29. Insulin glargine: a systematic review of a long-acting insulin analogue.
Wang F; Carabino JM; Vergara CM
Clin Ther; 2003 Jun; 25(6):1541-77, discussion 1539-40. PubMed ID: 12860485
[TBL] [Abstract][Full Text] [Related]
30. Insulin therapy in diabetes mellitus: how can the currently available injectable insulins be most prudently and efficaciously utilised?
Bell DS
Drugs; 2007; 67(13):1813-27. PubMed ID: 17722952
[TBL] [Abstract][Full Text] [Related]
31. New insulins in the treatment of diabetes mellitus.
Lindholm A
Best Pract Res Clin Gastroenterol; 2002 Jun; 16(3):475-92. PubMed ID: 12079270
[TBL] [Abstract][Full Text] [Related]
32. Beyond the era of NPH insulin--long-acting insulin analogs: chemistry, comparative pharmacology, and clinical application.
Owens DR; Bolli GB
Diabetes Technol Ther; 2008 Oct; 10(5):333-49. PubMed ID: 18715209
[TBL] [Abstract][Full Text] [Related]
33. Response to type 2 diabetes: epidemiologic trends, evolving pathogenic concepts, and recent changes in therapeutic approach.
Ramón Calle J
South Med J; 2005 Sep; 98(9):958-9. PubMed ID: 16218000
[No Abstract] [Full Text] [Related]
34. Spotlight on insulin detemir in type 1 and 2 diabetes mellitus.
Chapman TM; Perry CM
BioDrugs; 2005; 19(1):67-9. PubMed ID: 15691219
[TBL] [Abstract][Full Text] [Related]
35. Reducing mistakes in patient administration of glargine and lispro.
Schutta MH
Diabetes Care; 2002 Jun; 25(6):1098-9. PubMed ID: 12032124
[No Abstract] [Full Text] [Related]
36. Insulin analogues.
Heller SR
Curr Med Res Opin; 2002; 18 Suppl 1():s40-7. PubMed ID: 12365818
[TBL] [Abstract][Full Text] [Related]
37. Hypoglycemia and insulin analogues: is there a reduction in the incidence?
Heinemann L
J Diabetes Complications; 1999; 13(2):105-14. PubMed ID: 10432175
[TBL] [Abstract][Full Text] [Related]
38. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
Bode BW
Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
[TBL] [Abstract][Full Text] [Related]
39. Humalog (lispro) for type 2 diabetes.
Esposito K; Capuano A; Giugliano D
Expert Opin Biol Ther; 2012 Nov; 12(11):1541-50. PubMed ID: 23043233
[TBL] [Abstract][Full Text] [Related]
40. Glucose-lowering effect and glycaemic variability of insulin glargine, insulin detemir and insulin lispro protamine in people with type 1 diabetes.
Derosa G; Franzetti I; Querci F; Romano D; D'Angelo A; Maffioli P
Diabetes Obes Metab; 2015 Jun; 17(6):554-559. PubMed ID: 25694300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
